Item Type | Name |
Concept
|
Acetylcysteine
|
Concept
|
Administration, Oral
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Arthritis, Rheumatoid
|
Concept
|
Asthma
|
Concept
|
Aspergillosis, Allergic Bronchopulmonary
|
Concept
|
Autoantibodies
|
Concept
|
Biopsy
|
Concept
|
Carbon Monoxide
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
Concept
|
Cell Separation
|
Concept
|
Centrifugation, Density Gradient
|
Concept
|
Chicago
|
Concept
|
C-Reactive Protein
|
Concept
|
Guinea Pigs
|
Concept
|
Connective Tissue Diseases
|
Concept
|
Cytochalasin B
|
Concept
|
Cause of Death
|
Concept
|
Dogs
|
Concept
|
Cyclohexanecarboxylic Acids
|
Concept
|
Glucocorticoids
|
Concept
|
Hernia, Hiatal
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Lung Volume Measurements
|
Concept
|
Erythropoietin
|
Concept
|
Exercise Therapy
|
Concept
|
Dermatomyositis
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Double-Blind Method
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Gene Expression Regulation
|
Concept
|
Decision Making
|
Concept
|
Killer Cells, Natural
|
Concept
|
Forced Expiratory Volume
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
Concept
|
Drug Labeling
|
Concept
|
Hydrogen-Ion Concentration
|
Concept
|
Environmental Exposure
|
Concept
|
Eosinophils
|
Concept
|
Leukocytes, Mononuclear
|
Concept
|
Health Services Accessibility
|
Concept
|
Lung Diseases
|
Concept
|
Leukocytes
|
Concept
|
Immunoglobulin E
|
Concept
|
Pharmacogenetics
|
Concept
|
Phospholipases A
|
Concept
|
Models, Genetic
|
Concept
|
Pneumonia, Viral
|
Concept
|
Illinois
|
Concept
|
N-Formylmethionine Leucyl-Phenylalanine
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Mutation
|
Concept
|
Patient Education as Topic
|
Concept
|
Phosphodiesterase Inhibitors
|
Concept
|
Lung Neoplasms
|
Concept
|
Sjogren's Syndrome
|
Concept
|
Physician's Role
|
Concept
|
Platelet Activating Factor
|
Concept
|
Fetal Blood
|
Concept
|
Drug Prescriptions
|
Concept
|
Pulmonary Emphysema
|
Concept
|
Regional Blood Flow
|
Concept
|
Regression Analysis
|
Concept
|
Registries
|
Concept
|
Risk Factors
|
Concept
|
Pulmonary Circulation
|
Concept
|
Quinacrine
|
Concept
|
Pyridazines
|
Concept
|
Radiography
|
Concept
|
Cohort Studies
|
Concept
|
Scleroderma, Systemic
|
Concept
|
Respiratory Function Tests
|
Concept
|
Risk
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Humans
|
Concept
|
Hypertension, Pulmonary
|
Concept
|
Cluster Analysis
|
Concept
|
SRS-A
|
Concept
|
Tomography, X-Ray Computed
|
Concept
|
Superoxides
|
Concept
|
Statistics as Topic
|
Concept
|
Lipoxygenase Inhibitors
|
Concept
|
Practice Guidelines as Topic
|
Concept
|
Genetic Variation
|
Concept
|
Total Lung Capacity
|
Concept
|
Proportional Hazards Models
|
Concept
|
Risk Assessment
|
Concept
|
Antibodies, Antineutrophil Cytoplasmic
|
Concept
|
Inhalation Exposure
|
Concept
|
Matrix Metalloproteinase 7
|
Concept
|
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
|
Concept
|
Prevalence
|
Concept
|
Fatty Acids, Omega-3
|
Concept
|
Observer Variation
|
Concept
|
Lupus Erythematosus, Systemic
|
Concept
|
Lymph Nodes
|
Concept
|
Eicosanoids
|
Concept
|
Comorbidity
|
Concept
|
Occupational Exposure
|
Concept
|
Case-Control Studies
|
Concept
|
Sequence Analysis, DNA
|
Concept
|
Minority Groups
|
Concept
|
Treatment Outcome
|
Concept
|
Sarcoidosis, Pulmonary
|
Concept
|
Arachidonic Acid
|
Concept
|
Cyclooxygenase Inhibitors
|
Concept
|
Mice, Knockout
|
Concept
|
Telomerase
|
Concept
|
CA-125 Antigen
|
Concept
|
Th2 Cells
|
Concept
|
Antirheumatic Agents
|
Concept
|
Decision Support Systems, Clinical
|
Concept
|
Myeloblastin
|
Concept
|
Leukotriene Antagonists
|
Concept
|
Cross-Over Studies
|
Concept
|
In Situ Hybridization, Fluorescence
|
Concept
|
Microscopic Angioscopy
|
Concept
|
Matrix Metalloproteinase 2
|
Concept
|
Early Diagnosis
|
Concept
|
Inducible T-Cell Co-Stimulator Protein
|
Concept
|
Proteomics
|
Concept
|
Eosinophil Granule Proteins
|
Concept
|
Carcinoma, Small Cell
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
Concept
|
Matrix Metalloproteinase 9
|
Concept
|
Gene Expression Profiling
|
Concept
|
Phenyl Ethers
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Mice
|
Concept
|
Pulmonary Diffusing Capacity
|
Concept
|
Pyrimidines
|
Concept
|
Receptors, Muscarinic
|
Concept
|
Surveys and Questionnaires
|
Concept
|
Rats, Inbred Strains
|
Concept
|
Rheumatoid Factor
|
Concept
|
Ribonucleases
|
Concept
|
Mucin-5B
|
Concept
|
Severity of Illness Index
|
Concept
|
Chemokine CXCL13
|
Concept
|
Host-Pathogen Interactions
|
Concept
|
Idiopathic Interstitial Pneumonias
|
Concept
|
Acute Lung Injury
|
Concept
|
Propensity Score
|
Concept
|
Rats
|
Concept
|
Triazoles
|
Concept
|
High-Throughput Nucleotide Sequencing
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Concept
|
Eosinophil Peroxidase
|
Concept
|
Sex Factors
|
Concept
|
Vital Capacity
|
Concept
|
Medication Therapy Management
|
Concept
|
3',5'-Cyclic-AMP Phosphodiesterases
|
Concept
|
Multivariate Analysis
|
Concept
|
Logistic Models
|
Concept
|
Survival Analysis
|
Concept
|
Drug Monitoring
|
Concept
|
Reproducibility of Results
|
Concept
|
Patient Satisfaction
|
Concept
|
Treatment Failure
|
Concept
|
Lung Diseases, Interstitial
|
Concept
|
Survival Rate
|
Concept
|
ATP-Binding Cassette Transporters
|
Concept
|
Phospholipases A2
|
Concept
|
Early Detection of Cancer
|
Concept
|
Vascular Cell Adhesion Molecule-1
|
Concept
|
Hematologic Neoplasms
|
Concept
|
Health Care Surveys
|
Concept
|
GTPase-Activating Proteins
|
Concept
|
Medical Order Entry Systems
|
Concept
|
Transcriptome
|
Concept
|
Pulmonary Disease, Chronic Obstructive
|
Concept
|
Cyclic Nucleotide Phosphodiesterases, Type 4
|
Concept
|
Genome-Wide Association Study
|
Concept
|
Kaplan-Meier Estimate
|
Concept
|
Idiopathic Pulmonary Fibrosis
|
Concept
|
Alveolitis, Extrinsic Allergic
|
Concept
|
Antibodies, Antinuclear
|
Concept
|
Aspergillus
|
Concept
|
Cations
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Diagnostic Tests, Routine
|
Concept
|
Disease Models, Animal
|
Concept
|
DNA Helicases
|
Concept
|
Exoribonucleases
|
Concept
|
Fever
|
Concept
|
Follow-Up Studies
|
Concept
|
Kinetics
|
Concept
|
Longitudinal Studies
|
Concept
|
Lymphocyte Activation
|
Concept
|
Lymphocytes
|
Concept
|
Mixed Connective Tissue Disease
|
Concept
|
Monitoring, Physiologic
|
Concept
|
Patient Compliance
|
Concept
|
Predictive Value of Tests
|
Concept
|
Prospective Studies
|
Concept
|
Pulmonary Fibrosis
|
Concept
|
Pyridinium Compounds
|
Concept
|
Pyridones
|
Concept
|
Respiration, Artificial
|
Concept
|
Retrospective Studies
|
Concept
|
Serine Endopeptidases
|
Concept
|
Radiography, Thoracic
|
Concept
|
Eicosapentaenoic Acid
|
Concept
|
Interleukin-5
|
Concept
|
Telomere
|
Concept
|
Hospital Mortality
|
Concept
|
Leukotriene C4
|
Concept
|
Macrolides
|
Concept
|
Point-of-Care Systems
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Polymorphism, Single Nucleotide
|
Concept
|
Genomics
|
Concept
|
MicroRNAs
|
Concept
|
Protein Kinase Inhibitors
|
Concept
|
Pulmonary Aspergillosis
|
Academic Article
|
Churg-Strauss syndrome.
|
Academic Article
|
Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis.
|
Academic Article
|
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
|
Academic Article
|
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
|
Academic Article
|
Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes.
|
Academic Article
|
Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease.
|
Academic Article
|
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort.
|
Academic Article
|
N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia.
|
Academic Article
|
Allergic and Noninvasive Infectious Pulmonary Aspergillosis Syndromes.
|
Academic Article
|
CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.
|
Academic Article
|
Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.
|
Academic Article
|
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.
|
Academic Article
|
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.
|
Academic Article
|
Telomere length and genetic variant associations with interstitial lung disease progression and survival.
|
Academic Article
|
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
|
Academic Article
|
Reply to Lescoat et al. and to Khamis et al.
|
Academic Article
|
Anti-RNA binding protein positivity in idiopathic interstitial pneumonia.
|
Academic Article
|
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Occupational Burden in Chronic Respiratory Disease: Call for Recognition, Training, and Data Capture.
|
Academic Article
|
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat.
|
Academic Article
|
Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease.
|
Academic Article
|
Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.
|
Academic Article
|
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Diagnostic test interpretation and referral delay in patients with interstitial lung disease.
|
Academic Article
|
Recognition and Management of Myositis-Associated Rapidly Progressive Interstitial Lung Disease.
|
Academic Article
|
Gender in idiopathic pulmonary fibrosis diagnosis: time to address unconscious bias.
|
Academic Article
|
CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA.
|
Academic Article
|
T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival.
|
Academic Article
|
Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Myositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype.
|
Academic Article
|
Gender equity in interstitial lung disease.
|
Academic Article
|
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19.
|
Academic Article
|
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations.
|
Academic Article
|
Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis.
|
Academic Article
|
Automated CT Analysis of Major Forms of Interstitial Lung Disease.
|
Academic Article
|
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.
|
Academic Article
|
Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases.
|
Academic Article
|
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.
|
Academic Article
|
Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT.
|
Academic Article
|
Correction to: Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT.
|
Academic Article
|
The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus.
|
Academic Article
|
Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.
|
Academic Article
|
Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging.
|
Academic Article
|
Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment.
|
Academic Article
|
Hospitalizations in patients with idiopathic pulmonary fibrosis.
|
Academic Article
|
Rituximab for interstitial pneumonia with autoimmune features at two medical centres.
|
Academic Article
|
High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
|
Academic Article
|
Lung function trajectory in progressive fibrosing interstitial lung disease.
|
Academic Article
|
Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease.
|
Academic Article
|
Occupational Exposures in Rheumatoid Arthritis-related Airway Disease: A Missing Link?
|
Academic Article
|
Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry.
|
Academic Article
|
Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard.
|
Academic Article
|
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
|
Academic Article
|
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.
|
Academic Article
|
Mortality Risk From COVID-19 Among Unvaccinated Subjects With Autoimmune Phenotypes of Interstitial Lung Disease.
|
Academic Article
|
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study.
|
Academic Article
|
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
|
Academic Article
|
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia.
|
Academic Article
|
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults.
|
Concept
|
Clinical Studies as Topic
|
Concept
|
Adalimumab
|
Concept
|
Pulmonologists
|
Concept
|
Radiologists
|
Concept
|
Tobacco Smoking
|
Concept
|
Endothelin A Receptor Antagonists
|
Concept
|
Voriconazole
|
Academic Article
|
Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts.
|
Academic Article
|
PhIP-Seq uncovers novel autoantibodies and unique endotypes in interstitial lung disease.
|
Academic Article
|
Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologies.
|
Academic Article
|
Treatable traits: a comprehensive precision medicine approach in interstitial lung disease.
|
Academic Article
|
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.
|
Academic Article
|
Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease.
|
Academic Article
|
Abnormalities on baseline chest imaging are risk factors for immune checkpoint inhibitor associated pneumonitis.
|
Academic Article
|
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
|
Academic Article
|
Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis.
|
Academic Article
|
Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis.
|
Academic Article
|
Pulmonary Alveolar Proteinosis-associated Pulmonary Fibrosis: Evolutional Changes and Radiologic-Pathologic Correlation.
|
Academic Article
|
Risk Factors for Hospital Readmission in Patients with Interstitial Lung Disease.
|
Academic Article
|
Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes.
|
Academic Article
|
Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosis.
|
Academic Article
|
Implementation of an Interstitial Lung Abnormality Clinic and Multidisciplinary Discussion.
|
Academic Article
|
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis.
|
Academic Article
|
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease.
|
Academic Article
|
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis.
|